- Confirmed: 这个参考离子已经通过手动审计得到确认和验证。
- Reliable: 这个参考离子可能在特定的解剖组织环境中高度保守。
- Unreliable: 这个参考离子具有较高的排名价值,但缺乏可重复性。
- Unavailable: 由于排名价值低且缺乏可重复性,这个参考离子不应用于注释。
Found 15 Reference Ions Near m/z 415.2244
NovoCell ID | m/z | Mass Window | Metabolite | Ranking | Anatomy Context |
---|---|---|---|---|---|
MSI_000043158 Reliable | 415.2263 | 415.2261 ~ 415.2268 MzDiff: 2.8 ppm |
(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside (BioDeep_00000020026) Formula: C21H34O8 (414.2254) |
14.99 (95%) | Homo sapiens [UBERON:0001043] esophagus |
MSI_000052758 Reliable | 415.2338 | 415.2333 ~ 415.234 MzDiff: 2.7 ppm |
Riboflavin (Vitamin B2) (BioDeep_00000001427) Formula: C17H20N4O6 (376.1383) |
6.35 (100%) | DESI [NOVOCELL:BACKGROUND] blank |
MSI_000063237 Reliable | 415.2213 | 415.2213 ~ 415.2214 MzDiff: 0.1 ppm |
7-Hydroxymitragynine (BioDeep_00000175102) Formula: C23H30N2O5 (414.2155) |
5.12 (100%) | Mus musculus [UBERON:0000956] cerebral cortex |
MSI_000065184 Reliable | 415.2254 | 415.2251 ~ 415.2256 MzDiff: 1.9 ppm |
(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside (BioDeep_00000020026) Formula: C21H34O8 (414.2254) |
5.09 (100%) | Homo sapiens [UBERON:0001155] colon |
MSI_000047668 Unreliable | 415.2261 | 415.2261 ~ 415.2261 MzDiff: none |
(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside (BioDeep_00000020026) Formula: C21H34O8 (414.2254) |
2.18 (100%) | Homo sapiens [UBERON:0013067] colorectal mucosa |
MSI_000051919 Unreliable | 415.2275 | 415.2275 ~ 415.2275 MzDiff: none |
(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside (BioDeep_00000020026) Formula: C21H34O8 (414.2254) |
2.38 (100%) | Homo sapiens [UBERON:0001052] rectum |
MSI_000051939 Unreliable | 415.2218 | 415.2218 ~ 415.2218 MzDiff: none |
CID 9844747 (BioDeep_00000179081) Formula: C22H26FN3O4 (415.1907) |
2.38 (100%) | Homo sapiens [UBERON:0001052] rectum |
MSI_000052613 Unreliable | 415.2325 | 415.2325 ~ 415.2325 MzDiff: none |
Riboflavin (Vitamin B2) (BioDeep_00000001427) Formula: C17H20N4O6 (376.1383) |
1.21 (100%) | Homo sapiens [UBERON:0001052] rectum |
MSI_000053135 Unreliable | 415.2177 | 415.2177 ~ 415.2177 MzDiff: none |
Eplerenone (BioDeep_00000002302) Formula: C24H30O6 (414.2042) |
2.93 (100%) | DESI [NOVOCELL:BACKGROUND] blank |
MSI_000027486 Unreliable | 415.2215 | 415.2212 ~ 415.2218 MzDiff: 2.7 ppm |
7-Hydroxymitragynine (BioDeep_00000175102) Formula: C23H30N2O5 (414.2155) |
3.78 (50%) | Mus musculus [UBERON:0002048] lung |
MSI_000025251 Unreliable | 415.223 | 415.223 ~ 415.223 MzDiff: none |
Buclizine (BioDeep_00000006601) Formula: C28H33ClN2 (432.2332) |
1.68 (100%) | Mus musculus [UBERON:0004269] upper arm connective tissue |
MSI_000056288 Unavailable | 415.2267 | 415.2267 ~ 415.2267 MzDiff: none |
Buclizine (BioDeep_00000006601) Formula: C28H33ClN2 (432.2332) |
-0.6 (100%) | Homo sapiens [UBERON:0007779] transudate |
MSI_000058570 Unreliable | 415.2221 | 415.2221 ~ 415.2221 MzDiff: none |
7-Hydroxymitragynine (BioDeep_00000175102) Formula: C23H30N2O5 (414.2155) |
1.14 (100%) | Mus musculus [UBERON:0001950] neocortex |
MSI_000059936 Unavailable | 415.2221 | 415.2221 ~ 415.2221 MzDiff: none |
7-Hydroxymitragynine (BioDeep_00000175102) Formula: C23H30N2O5 (414.2155) |
-0.72 (100%) | Mus musculus [UBERON:0002298] brainstem |
MSI_000060685 Unavailable | 415.2221 | 415.2221 ~ 415.2221 MzDiff: none |
7-Hydroxymitragynine (BioDeep_00000175102) Formula: C23H30N2O5 (414.2155) |
-0.42 (100%) | Mus musculus [UBERON:0002421] hippocampal formation |
Found 41 Sample Hits
Metabolite | Species | Sample | |
---|---|---|---|
7-Hydroxymitragynine Formula: C23H30N2O5 (414.2155) Adducts: [M+H]+ (Ppm: 3.2) |
Mus musculus (Lung) |
image1Resolution: 40μm, 187x165
Fig. 2 MALDI-MSI data from the same mouse lung tissue analyzed in Fig. 1. A: Optical image of the post-MSI, H&E-stained tissue section. B–D, F–G: Ion images of (B) m/z 796.6855 ([U13C-DPPC+Na]+), (C) m/z 756.5514 ([PC32:0+Na]+), (D) m/z 765.6079 ([D9-PC32:0+Na]+), (F) m/z 754.5359 ([PC32:1+Na]+), and (G) m/z 763.5923 ([D9-PC32:1+Na]+). E, H: Ratio images of (E) [D9-PC32:0+Na]+:[PC32:0+Na]+ and (H) [D9-PC32:1+Na]+:[PC32:1+Na]+. Part-per-million (ppm) mass errors are indicated in parentheses. All images were visualized using total-ion-current normalization and using hotspot removal (high quantile = 99%). DPPC = PC16:0/16:0. U13C-DPPC, universally 13C-labeled dipalmitoyl PC; PC, phosphatidylcholine; MSI, mass spectrometry imaging; H&E, hematoxylin and eosin.
Fig 1-3, Fig S1-S3, S5 |
|
Buclizine Formula: C28H33ClN2 (432.2332) Adducts: [M+H-H2O]+ (Ppm: 16.7) |
Mus musculus (Left upper arm) |
357_l_total ion countResolution: 50μm, 97x131
Diseased |
|
7-Hydroxymitragynine Formula: C23H30N2O5 (414.2155) Adducts: [M+H]+ (Ppm: 3.7) |
Mus musculus (Lung) |
image3Resolution: 40μm, 146x190
Fig. 4 MALDI-MSI data of mouse lung tissue after administration with D9-choline and U13C-DPPC–containing Poractant alfa surfactant (labels administered 12 h prior to tissue collection). Ion images of (A) m/z 796.6856 ([U13C-DPPC+Na]+), (B) m/z 756.5154 [PC32:0+Na]+), and (C) m/z 765.6079 ([D9-PC32:0+Na]+). D: Overlay image of [U13C-PC32:0+Na]+ (red) and [D9-PC32:0+Na]+ (green). Part-per-million (ppm) mass errors are indicated in parentheses. All images were visualized using total-ion-current normalization and using hotspot removal (high quantile = 99%). DPPC = PC16:0/16:0. MSI, mass spectrometry imaging; PC, phosphatidylcholine; U13C-DPPC, universally 13C-labeled dipalmitoyl PC. |
|
7-Hydroxymitragynine Formula: C23H30N2O5 (414.2155) Adducts: [M+H]+ (Ppm: 3.7) |
Mus musculus (Lung) |
image4Resolution: 40μm, 162x156
Fig 6c
Fig. 6 MALDI-MSI of U13C-PC16:0/16:0 acyl chain remodeling. A: Averaged MALDI mass spectrum from lung tissue collected from mice euthanized 12 h after administration of D9-choline and U13C-DPPC–containing Poractant alfa surfactant. The ion at m/z 828.6321 is assigned as the [M+Na]+ ion of 13C24-PC16:0_20:4 formed by acyl remodeling of U13C-PC16:0/16:0. The “NL” value refers to the intensity of the base peak in the full range MS1 spectrum. B: MS/MS spectrum of precursor ions at m/z 828.5 ± 0.5 with fragment ions originating from [13C24-PC16:0_20:4+Na]+ annotated. Part-per-million (ppm) mass errors are provided in parentheses. C, D: MALDI-MSI data of [U13C-DPPC+Na]+ (blue), [PC36:4+Na]+ (green) and [13C24-PC16:0_20:4+Na]+ (red) in lung tissue collected from mice (C) 12 h and (D) 18 h after label administration. All images were visualized using total-ion-current normalization and hotspot removal (high quantile = 99%). MS/MS, tandem mass spectrometry; MSI, mass spectrometry imaging; PC, phosphatidylcholine; U13C-DPPC, universally 13C-labeled dipalmitoyl PC. |
|
Buclizine Formula: C28H33ClN2 (432.2332) Adducts: [M+H-H2O]+ (Ppm: 19.6) |
Mus musculus (Lung) |
image2Resolution: 40μm, 550x256
Supplementary Figure S6. Ion distribution images for (a) [PC36:4+Na]+ (m/z 804.5514) and (b)
[PC38:6+Na]+ (m/z 828.5515) obtained from mouse lung tissue collected 6 h after administration of D9-
choline and U13C-DPPC–containing CHF5633. Parts-per-million (ppm) mass errors are indicated in
parentheses. (c) Magnification of the boxed region in (a) with selected bronchiolar regions outlined in
white boxes. (d) The corresponding H&E-stained tissue section with the same selected bronchiolar
regions outlined in black boxes. These data demonstrate the co-localisation of the polyunsaturated lipids
PC36:4 and PC38:6 with the bronchiolar regions of the lung. All MSI images were visualised using
total ion current normalisation and hotspot removal (high quantile = 99%). |
|
Buclizine Formula: C28H33ClN2 (432.2332) Adducts: [M+H-H2O]+ (Ppm: 13.3) |
Homo sapiens (esophagus) |
LNTO22_1_4Resolution: 17μm, 82x80
|
|
7-Hydroxymitragynine Formula: C23H30N2O5 (414.2155) Adducts: [M+H]+ (Ppm: 6.9) |
Homo sapiens (esophagus) |
LNTO29_16_2Resolution: 17μm, 95x101
|
|
(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside Formula: C21H34O8 (414.2254) Adducts: [M+H]+ (Ppm: 14) |
Homo sapiens (esophagus) |
LNTO22_1_9Resolution: 75μm, 89x74
|
|
Buclizine Formula: C28H33ClN2 (432.2332) Adducts: [M+H-H2O]+ (Ppm: 14.3) |
Mus musculus (Liver) |
Salmonella_final_pos_recalResolution: 17μm, 691x430
A more complete and holistic view on host–microbe interactions is needed to understand the physiological and cellular barriers that affect the efficacy of drug treatments and allow the discovery and development of new therapeutics. Here, we developed a multimodal imaging approach combining histopathology with mass spectrometry imaging (MSI) and same section imaging mass cytometry (IMC) to study the effects of Salmonella Typhimurium infection in the liver of a mouse model using the S. Typhimurium strains SL3261 and SL1344. This approach enables correlation of tissue morphology and specific cell phenotypes with molecular images of tissue metabolism. IMC revealed a marked increase in immune cell markers and localization in immune aggregates in infected tissues. A correlative computational method (network analysis) was deployed to find metabolic features associated with infection and revealed metabolic clusters of acetyl carnitines, as well as phosphatidylcholine and phosphatidylethanolamine plasmalogen species, which could be associated with pro-inflammatory immune cell types. By developing an IMC marker for the detection of Salmonella LPS, we were further able to identify and characterize those cell types which contained S. Typhimurium.
[dataset] Nicole Strittmatter. Holistic Characterization of a Salmonella Typhimurium Infection Model Using Integrated Molecular Imaging, metabolights_dataset, V1; 2022. https://www.ebi.ac.uk/metabolights/MTBLS2671. |
|
(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside Formula: C21H34O8 (414.2254) Adducts: [M+H]+ (Ppm: 17.2) |
Homo sapiens (esophagus) |
LNTO30_8M_1Resolution: 17μm, 69x54
|
|
(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside Formula: C21H34O8 (414.2254) Adducts: [M+H]+ (Ppm: 15.7) |
Homo sapiens (colorectal adenocarcinoma) |
80TopL, 50TopR, 70BottomL, 60BottomR-profileResolution: 17μm, 137x136
The human colorectal adenocarcinoma sample was excised during a surgical operation performed at the Imperial College Healthcare NHS Trust. The sample and procedures were carried out in accordance with ethical approval (14/EE/0024). |
|
Eplerenone Formula: C24H30O6 (414.2042) Adducts: [M+H]+ (Ppm: 19) |
Homo sapiens (colorectal adenocarcinoma) |
520TopL, 490TopR, 510BottomL, 500BottomR-profileResolution: 17μm, 147x131
The human colorectal adenocarcinoma sample was excised during a surgical operation performed at the Imperial College Healthcare NHS Trust. The sample and procedures were carried out in accordance with ethical approval (14/EE/0024). |
|
Riboflavin (Vitamin B2) Formula: C17H20N4O6 (376.1383) Adducts: [M+K]+ (Ppm: 17.7) |
Homo sapiens (colorectal adenocarcinoma) |
520TopL, 490TopR, 510BottomL, 500BottomR-profileResolution: 17μm, 147x131
The human colorectal adenocarcinoma sample was excised during a surgical operation performed at the Imperial College Healthcare NHS Trust. The sample and procedures were carried out in accordance with ethical approval (14/EE/0024). |
|
CID 9844747 Formula: C22H26FN3O4 (415.1907) Adducts: [M-H2O+NH4]+ (Ppm: 18.8) |
Homo sapiens (colorectal adenocarcinoma) |
439TopL, 409TopR, 429BottomL, 419BottomR-profileResolution: 17μm, 157x136
The human colorectal adenocarcinoma sample was excised during a surgical operation performed at the Imperial College Healthcare NHS Trust. The sample and procedures were carried out in accordance with ethical approval (14/EE/0024). |
|
CID 9844747 Formula: C22H26FN3O4 (415.1907) Adducts: [M-H2O+NH4]+ (Ppm: 11.1) |
Homo sapiens (NA) |
160TopL,130TopR,150BottomL,140BottomR-profileResolution: 17μm, 142x136
|
|
(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside Formula: C21H34O8 (414.2254) Adducts: [M+H]+ (Ppm: 16.9) |
Homo sapiens (NA) |
160TopL,130TopR,150BottomL,140BottomR-profileResolution: 17μm, 142x136
|
|
7-Hydroxymitragynine Formula: C23H30N2O5 (414.2155) Adducts: [M+H]+ (Ppm: 6.4) |
Homo sapiens (esophagus) |
LNTO29_16_3Resolution: 17μm, 108x107
|
|
(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside Formula: C21H34O8 (414.2254) Adducts: [M+H]+ (Ppm: 15.3) |
Homo sapiens (esophagus) |
LNTO26_7_1Resolution: 17μm, 75x74
|
|
Buclizine Formula: C28H33ClN2 (432.2332) Adducts: [M+H-H2O]+ (Ppm: 7.8) |
Homo sapiens (esophagus) |
LNTO26_7_2Resolution: 17μm, 135x101
|
|
(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside Formula: C21H34O8 (414.2254) Adducts: [M+H]+ (Ppm: 15.7) |
Homo sapiens (esophagus) |
LNTO26_7_3Resolution: 75μm, 82x88
|
|
(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside Formula: C21H34O8 (414.2254) Adducts: [M+H]+ (Ppm: 17.2) |
Homo sapiens (esophagus) |
TO31TResolution: 75μm, 56x54
|
|
(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside Formula: C21H34O8 (414.2254) Adducts: [M+H]+ (Ppm: 15.5) |
Homo sapiens (esophagus) |
TO29TResolution: 75μm, 56x48
|
|
Buclizine Formula: C28H33ClN2 (432.2332) Adducts: [M+H-H2O]+ (Ppm: 10.7) |
Homo sapiens (esophagus) |
TO41TResolution: 75μm, 69x43
|
|
(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside Formula: C21H34O8 (414.2254) Adducts: [M+H]+ (Ppm: 16.9) |
Homo sapiens (esophagus) |
LNTO30_8M_2Resolution: 75μm, 108x68
|
|
(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside Formula: C21H34O8 (414.2254) Adducts: [M+H]+ (Ppm: 16.9) |
Homo sapiens (esophagus) |
LNTO30_8M_3Resolution: 75μm, 69x54
|
|
(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside Formula: C21H34O8 (414.2254) Adducts: [M+H]+ (Ppm: 16.2) |
Homo sapiens (esophagus) |
LNTO30_8M_4Resolution: 75μm, 62x48
|
|
7-Hydroxymitragynine Formula: C23H30N2O5 (414.2155) Adducts: [M+H]+ (Ppm: 6.9) |
Homo sapiens (esophagus) |
LNTO30_8M_5Resolution: 75μm, 56x54
|
|
(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside Formula: C21H34O8 (414.2254) Adducts: [M+H]+ (Ppm: 16.7) |
Homo sapiens (esophagus) |
LNTO30_17_2Resolution: 75μm, 82x54
|
|
(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside Formula: C21H34O8 (414.2254) Adducts: [M+H]+ (Ppm: 15.7) |
Homo sapiens (esophagus) |
LNTO22_1_8Resolution: 75μm, 69x61
|
|
(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside Formula: C21H34O8 (414.2254) Adducts: [M+H]+ (Ppm: 15.7) |
Homo sapiens (esophagus) |
LNTO22_2_1Resolution: 75μm, 89x88
|
|
(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside Formula: C21H34O8 (414.2254) Adducts: [M+H]+ (Ppm: 14.8) |
Homo sapiens (esophagus) |
LNTO22_2_2Resolution: 75μm, 135x94
|
|
(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside Formula: C21H34O8 (414.2254) Adducts: [M+H]+ (Ppm: 15.5) |
Homo sapiens (esophagus) |
LNTO26_16_1Resolution: 75μm, 95x88
|
|
(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside Formula: C21H34O8 (414.2254) Adducts: [M+H]+ (Ppm: 17.4) |
Homo sapiens (esophagus) |
LNTO29_18_2Resolution: 75μm, 62x68
|
|
(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside Formula: C21H34O8 (414.2254) Adducts: [M+H]+ (Ppm: 16.7) |
Homo sapiens (esophagus) |
LNTO30_7_1Resolution: 75μm, 69x68
|
|
7-Hydroxymitragynine Formula: C23H30N2O5 (414.2155) Adducts: [M+H]+ (Ppm: 7.1) |
Homo sapiens (esophagus) |
LNTO30_7_2Resolution: 75μm, 82x68
|
|
7-Hydroxymitragynine Formula: C23H30N2O5 (414.2155) Adducts: [M+H]+ (Ppm: 1.5) |
Mus musculus (brain) |
Brain01_Bregma-3-88b_centroidResolution: 17μm, 265x320
|
|
7-Hydroxymitragynine Formula: C23H30N2O5 (414.2155) Adducts: [M+H]+ (Ppm: 3.5) |
Mus musculus (brain) |
Brain02_Bregma1-42_03Resolution: 17μm, 483x403
|
|
(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside Formula: C21H34O8 (414.2254) Adducts: [M+H]+ (Ppm: 17.7) |
Homo sapiens (colorectal adenocarcinoma) |
240TopL, 210TopR, 230BottomL, 220BottomR-centroidResolution: 50μm, 142x141
|
|
(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside Formula: C21H34O8 (414.2254) Adducts: [M+H]+ (Ppm: 16.9) |
Homo sapiens (colorectal adenocarcinoma) |
200TopL, 170TopR, 190BottomL, 180BottomR-centroidResolution: 50μm, 132x126
|
|
(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside Formula: C21H34O8 (414.2254) Adducts: [M+H]+ (Ppm: 18.1) |
Homo sapiens (colorectal adenocarcinoma) |
160TopL,130TopR,150BottomL,140BottomR-centroidResolution: 50μm, 142x136
|
|
(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside Formula: C21H34O8 (414.2254) Adducts: [M+H]+ (Ppm: 17.2) |
Homo sapiens (colorectal adenocarcinoma) |
120TopL, 90TopR, 110BottomL, 100BottomR-centroidResolution: 50μm, 132x136
|
|